Oral Solid Dose

  1. Formulation Of Crystalline Nanoparticles Enabling Superior Drug Load 8/13/2024

    Explore how bioavailability of poorly soluble APIs can be improved and patient compliance enhanced by reducing the size or number of tablets that a patient must take to achieve the required dose.

  2. The Future Of Oral Solid Dose Development And Innovation 2/27/2025

    Tom Sellig, CEO of Adare, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.

  3. Virtual Tour Of A CDMO Facility In Vandalia, OH 8/29/2024

    Take a virtual tour of a CDMO facility in Vandalia, Ohio, that serves as a global R&D and commercial manufacturing center of excellence. The facility is just one of the seven state-of-the-art sites in the global network.

  4. Patient- And Planet-Centric Bioavailability And Sustained Delivery

    By reducing the size of drug particles, nanoforming offers new opportunities — from increased bioavailability to sustained drug delivery. Discover the potential benefits supported by case studies.

  5. Innovative Microencapsulation Technology 8/29/2024

    Discover how microencapsulation by coacervation can transform your formulations, ensuring smooth mouthfeel, effective taste masking, and customized release profiles.

  6. Transforming Drug Delivery. Transforming Lives. 8/29/2024

    Watch this introduction to Adare Pharma Solutions, a global technology driven CDMO providing product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical industry. 

  7. Improve The Bioavailability Of Poorly Soluble Drugs 3/19/2024

    KinetiSol is a fusion-based, solvent-free process that utilizes frictional and shear energies — in a fraction of the time of other amorphous solid dispersion technologies.

  8. Oral Solid Dosage Products: Water Activity And Primary Packaging Selection 7/17/2022

    Every individual oral solid dosage (OSD) product has different water activity initially and over time. Learn about USP <922> water activity and primary packaging selection of OSD products.

  9. Diffucaps Technology 8/29/2024

    Discover how Diffucaps technology offers precise drug release, tailored dosage, and enhanced solubility, while minimizing irritation.

  10. Taste Masking 101: Optimize Taste And Improve Patient Outcomes 6/28/2021

    Learn how swallowability and palatability play key factors related to patient acceptability and product development and about the variety of taste masking strategies including excipients, organoleptic and barrier coating approaches, and microencapsulation technologies.